BMJ No 7138 Volume 316

Press Releases Saturday 11 April 1998


BABY MILK MANUFACTURERS ARE BREAKING THE RULES
HORMONE RELEASING INTRAUTERINE DEVICE MAY BE AN ALTERATIVE TO HYSTERECTOMY
FULL TEXT OF THE BMJ NOW AVAILABLE ON THE WORLD WIDE WEB
NEED FOR HIV GUIDELINES FOR HEALTH WORKERS IN DEVELOPING COUNTRIES



BABY MILK MANUFACTURERS ARE BREAKING THE RULES

(Violation of the international code of marketing of breast milk
substitutes: prevalence in four countries)

In a paper published in this week's BMJ Anna Taylor, on behalf of the
Interagency Group on Breastfeeding Monitoring, reveals that baby milk
manufacturers are breaking the international code of marketing breast milk
substitutes, which was adopted by the World Health Assembly in 1981.

The code was introduced to encourage mothers to breast feed their babies,
in an attempt to prevent 1.5 million needless infant deaths each year and
to protect mothers from pressure to use substitute breast milk.  Taylor's
study is the first of its kind and covered cities in Bangladesh, Poland,
South Africa and Thailand.  The author found that baby milk manufacturers
violate the code by continuing to send free gifts to mothers or indirectly
apply marketing pressure through free gifts or samples to health workers.

Taylor concludes that unless there is a commitment to enforce and monitor
the World Health Assembly code nationally, breast feeding will not be
protected from the commercial pressures  from substitute manufacturers.

Contact:
Professor Andrew Tomkins, Centre for International Child Health, Institute
of Child Health, 30 Guilford Street, London
atomkins{at}ich.ucl.ac.uk
 

(Protecting breast feeding from breast milk substitutes)

In an accompanying editorial in this week's BMJ, Dr Anthony Costello, from
the Institute of Child Health, says that like the tobacco companies, the
promotional activities of the baby milk manufacturers will only be brought
into line when they face substantial claims for damages from consumers.  He
suggests that in the meantime countries and monitoring agencies can take
four steps to prevent commercial pressures being placed on mothers.

Firstly, Costello advocates that governments should incorporate the
articles of the code of marketing substitutes for breast milk into national
legislation.  Secondly, he suggests that monitoring for overt violations
should be more systematic in an attempt to deter such promotional
activities.  The author believes that doctors should also be warned that
the baby milk manufacturers try to gain endorsement by association by
allying themselves with prestigious national bodies, such as by sponsoring
a paediatric conference.

Finally, Costello accepts that, as with antismoking campaigns, legislation
and monitoring are only part of the broader strategy to protect mothers and
that positive public opinion towards breast feeding may be even more
crucial.  He says that training midwives and doctors in lactation
counselling (including guidance for HIV positive mothers); breast feeding
advertisements; an extension of the baby friendly hospital initiative and
financial support for advocacy groups could all go some way to counteract
the manufacturers propaganda.

Contact:
Dr Anthony Costello, Reader in International Child Health, Institute of
Child Health, University College, London
a.costello@ich.ucl.ac.uk (best means of contact)
or
Professor Harshpal Sachdev, Division of Clinical Epidemiology. Department
of Paediatrics, Maulana Azad medical College, New Delhi, India
 
 

HORMONE RELEASING INTRAUTERINE DEVICE MAY BE AN ALTERATIVE TO HYSTERECTOMY

(Open randomised study of use of levonorgestrel releasing intrauterine
system as alternative to hysterectomy)

Most hysterectomies are carried out to treat excessive menstrual bleeding
(menorrhagia), say Lahteenmaki et al, in this week's BMJ.  During a six
month study in Finland, women scheduled for a hysterectomy to treat
menorrhagia were offered the alternative of a hormone releasing
(levonorgestrel) intrauterine device to control their bleeding and pain.
At the end of the six month period the authors found that two thirds (64
per cent) of the women opted to cancel their operation and continue with
the intrauterine treatment.

As this result persisted beyond twelve months, Lahteenmaki et al conclude
that the hormone releasing intrauterine system (which also acts as a
contraceptive) is an effective and acceptable alternative to hysterectomy
in the treatment of menorrhagia, particularly for sufferers who wish to
maintain their fertility.

Contact:
Dr P Lahteenmaki, Leiras Oy, Pansiontie 47, PO Box 415, FIN-20101, Turku,
Finland
pekka.laehteenmaeki{at}leiras.fi


FULL TEXT OF THE BMJ NOW AVAILABLE ON THE WORLD WIDE WEB

(The BMJ's website scales up.  Now it provides free access to full text)

This week, for the very first time, the BMJ will appear in its full text
version on the world wide web (
www.bmj.com ) with free unrestricted access
for all.  In an editorial, Dr Tony Delamothe and Dr Richard Smith of the
BMJ discuss the uniqueness of the site and the advantages that it will
bring to surfers.  The full text of all BMJ articles will be available
worldwide at 00.01 London time on Friday mornings.  Extra material will be
posted on the website, including letters for which there is currently not
space in the paper version.  There will be a fully searchable archive of
the journal  back to the beginning of 1997 and eventually to 1994.
Visitors will be able to access around 150 collections of material on
subjects ranging from asthma through aging to end of life decisions.  They
can also register to be emailed the full contents list of the journal or
material published on selected topics.  All jobs advertised in the BMJ -
about 700 a week - will also be listed.

The authors go on to admit that they are unsure as to the format the
website will take in the future; as is usually the case with a new
medium, it is handled like old media until its unique properties are
recognised and exploited.  However, they feel strongly that even though
two per cent of the world's population are now estimated to be online, 75
per cent of the globe do not even have access to their own telephone.
Delamothe and Smith conclude that if the Internet is to be a means of
closing the information gap between the developed and developing world then
organisations such as the BMJ have an obligation to ensure that the world
wide web lives up to its name.

Contact:
Dr Richard Smith, Editor, BMJ, BMA House, Tavistock Square, London
100336.3120{at}compuserve.com
 

NEED FOR HIV GUIDELINES FOR HEALTH WORKERS IN DEVELOPING COUNTRIES

(Reducing the risk of nosocomial HIV infection in British health workers
working overseas:  role of post-exposure prophylaxis)

In an Education and Debate paper in this week's BMJ Dr Charles Gilks,
Liverpool School of Tropical Medicine, and David Wilkinson from the Medical
Research Council in South Africa examine the issue of the risk of
occupational HIV infection from patient to health worker in the developing
world.

The authors note that the prevalence of HIV infection among patients  is
very high in some poorer countries and that such regions tend to lack the
resources to implement adequate precautions to prevent transmission, as
well as equipment and facilities.  They also observe that health
professionals working in these areas are often relatively inexperienced
(for example medical students undertaking their elective) and therefore
they are more likely to inadvertently expose themselves to blood and other
body fluids.

With such effective post-exposure prophylaxis available, if an in-country
employer is not able to afford the cost and storage of such drugs then
should health workers be given a personal supply before travel   Gilks and
Wilkinson conclude that there is a need for realistic, usable guidelines
for both for those working overseas in medical environments and for their employers.

Contact:
Dr Charles Gilks, Senior Lecturer, Division of Tropical Medicine, Liverpool
School of Tropical Medicine, Liverpool gilks{at}liverpool.ac.uk
 
For accredited journalists
Embargoed press releases:
These are available from the Public Affairs Division, BMA House,
Tavistock Square, London WC1H 9JR (contact Jill Shepherd;jshepher{at}bma.org.uk)
 
and from
the EurekAlert website, run by the American Association for the
Advancement of Science (
www.eurekalert.org)
 
 
Please remember to mention the BMJ as source when publicising an article
and to inform your readers that they can read its full text on the
journal's web site (www.bmj.com).

 
 




Access jobs at BMJ Careers
Whats new online at Student 

BMJ